Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
INOVIO's INO-5401 in Combination with PD-1 Inhibitor Libtayo(R) (cemiplimab) Demonstrates 85% of Newly Diagnosed Glioblastoma Patients Are Alive 12 Months Following Treatment 2020-05-14 19:00
SciMount announces FDA approval of SMP-100's IND application for the treatment of Irritable Bowel Syndrome 2020-05-14 18:00
Novartis Singapore returns Job Support Scheme payout worth SGD3.7 Million; aids community efforts against COVID-19 2020-05-14 15:18
Experts Underscore Essential Role for Patient Blood Management in and beyond the COVID-19 Pandemic 2020-05-14 14:00
Halodine(R) Nasal and Oral Antiseptics Show Rapid Antiviral Activity Against SARS-CoV-2 (COVID-19) 2020-05-14 09:26
TYVYT® (Sintilimab Injection) ORIENT-2 Study Met its Primary Endpoint of Overall Survival in the Second-Line Treatment of Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma 2020-05-14 07:30
Hanwha Helps the Fight Against COVID-19 by Providing Life Park, a Smart Training Institute in the City of Yongin, Gyeonggi Province in Korea, as a Treatment Center 2020-05-14 07:00
Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020 2020-05-14 06:46
Hetero Enters Into a Licensing Agreement With Gilead Sciences, Inc. for the Manufacturing and Distribution of "Remdesivir" in 127 Countries, Including India, for COVID-19 2020-05-14 01:56
Telehealth to Experience Massive Growth with COVID-19 Pandemic, Says Frost & Sullivan 2020-05-14 01:05
DERMALOG Fever Detection Protects Draegerwerk AG Production 2020-05-13 21:10
First Patient Dosed with I-Mab's CD73 Antibody TJD5 in Phase 1/2 Clinical Trial in China for Advanced Solid Tumors 2020-05-13 20:00
Fluxergy Announces $30 Million to Expand Manufacturing Capacity of Its One-hour Point-of-care Diagnostic Testing System in Response to COVID-19 2020-05-13 18:41
Ascletis' THR- beta Agonist ASC41 Receives Approval for Clinical Trials of NASH Indication 2020-05-13 18:30
CMAB Biopharma's development and manufacturing platform successfully completes Q-1802 bispecific antibody project for QureBio within 9 months 2020-05-13 18:29
Cipla Enters Into a Licensing Agreement With Gilead to Expand Access to COVID-19 Treatment 2020-05-13 17:51
Big Start helps businesses secure PPE gear as global demand spikes 2020-05-13 14:00
Low-dose radiographs could reveal typical lung changes 2020-05-13 08:20
ChemPartner Assists the Mount Sinai Health System in Producing Reagent for COVID-19 Research 2020-05-12 23:03
China Biologic Products to Report First Quarter 2020 Financial Results 2020-05-12 20:30
1 567 568 569 570 571 958